Skip to content

Clearfield CLFD Issuance Of Common Stock Funded Through Shares Sold To Company

Issuance Of Common Stock Funded Through Shares Sold To Company at other companies

Bank of Marin Bancorp logo
Bank of Marin BancorpBMRC
$9K+12.5%
MillerKnoll logo
MillerKnollMLKN
$2.2M+22.2%
FMC Corporation logo
FMC CorporationFMC
$0-100%
Tyra Biosciences, Inc. logo
Tyra Biosciences, Inc.TYRA
$12.53M+473%
Evolus logo
EvolusEOLS
$0-100%
Paycom Software logo
Paycom SoftwarePAYC
$3.6M

Other financials

Income statement

See full
Revenue$34.4M-15.3%
Gross profit$11.2M-20.1%
Operating income-$2.1M-223%
Net income-$528.0K-140%
EPS (diluted)-$0.04-144%

Balance sheet

See full
Cash & equivalents$9.4M-67.4%
Total debt$10.9M-46.4%
Total equity$242.8M-8.7%
Total assets$263.5M-15.2%

Cash flow

See full
Operating cash flow-$1.1M-135%
CapEx$1.0M-23.0%
Free cash flow-$2.1M-221%

Valuation

See full
Market cap$511.37M-7.6%
Enterprise value$512.91M-5.9%
P/S3.8×-0.7×

Profitability

See full
Gross margin37.2%+4.4pp
Operating margin1.4%+0.9pp
Net margin-6.3%-9.1pp
FCF margin7.5%-9.1pp

Returns & leverage

See full
Return on equity-3.4%-4.5pp
Debt / equity0.0×
Current ratio12.8×+6.1×

Where this comes from

Reported directly by Clearfield in its filing.

Tagged under the XBRL concept clfd:IssuanceOfCommonStockFundedThroughSharesSoldToCompany.

The official record: Clearfield’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clearfield's issuance of common stock funded through shares sold to company.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clearfield's issuance of common stock funded through shares sold to company?
Clearfield (CLFD) reported issuance of common stock funded through shares sold to company of $1.97M in Q1 2026.
How has Clearfield's issuance of common stock funded through shares sold to company changed year-over-year?
Clearfield's issuance of common stock funded through shares sold to company increased by 2137.5% year-over-year, from $88K to $1.97M.
What is the long-term trend for Clearfield's issuance of common stock funded through shares sold to company?
Over 3 years (2021 to 2025), Clearfield's issuance of common stock funded through shares sold to company has grown at a 25.8% compound annual growth rate (CAGR), from $1.27M to $2.53M.
What does issuance of common stock funded through shares sold to company mean?
Measures the cash proceeds received from the issuance of common stock, specifically related to internal employee or executive share purchase programs. This reflects capital inflows generated through equity-based compensation and ownership alignment strategies.